Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MBX Biosciences, Inc. - Common Stock
(NQ:
MBX
)
56.58
+2.73 (+5.07%)
Streaming Delayed Price
Updated: 12:03 PM EDT, Jun 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about MBX Biosciences, Inc. - Common Stock
< Previous
1
2
Next >
These stocks that are showing activity before the opening bell on Friday.
↗
June 12, 2026
Via
Chartmill
Chief Medical Officer Sells MBX for $2.7 Million After Monster 2026 Run
↗
May 27, 2026
MBX Biosciences, a clinical-stage biotech developing peptide therapies, reported a notable insider sale after a year of rapid stock gains.
Via
The Motley Fool
Topics
Regulatory Compliance
MBX Biosciences Obesity Day Spotlights Monthly GLP-1 Hope and Pipeline Push
↗
May 11, 2026
MBX Biosciences (NASDAQ:MBX) used its Obesity Day event to outline preliminary clinical data for its lead obesity candidate MBX 4291, introduce a new preclinical obesity program and reiterate key...
Via
MarketBeat
3 Overlooked Stocks Set to Soar in 2026
↗
May 05, 2026
These relatively small biotechs have recent catalysts that haven't yet been fully priced into their stocks.
Via
The Motley Fool
MBX Stock Soars Pre-Market After Investigational Hypoparathyroidism Drug Yields Positive Results In Study
↗
September 22, 2025
Via
Stocktwits
Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase
↗
April 22, 2026
MBX Biosciences targets endocrine and metabolic disorders with novel peptide therapies, advancing candidates across several clinical phases.
Via
The Motley Fool
MBX CEO Buys 18,500 Shares as Stock Jumps 270% This Past Year. Here's What You Should Know
↗
March 26, 2026
Focused on precision therapies for endocrine disorders, this biotech firm reported a notable insider buy amid a year of sharp stock gains.
Via
The Motley Fool
Topics
Regulatory Compliance
The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
December 22, 2025
As the curtains draw on 2025, the biotechnology sector has emerged as the undisputed champion of the equity markets, staging a dramatic year-end rally that has caught even the most optimistic analysts...
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones
↗
December 03, 2025
One fast-rising biotech is gearing up for pivotal trials just as a major specialist fund walks away—here’s what long-term investors should take from that divergence.
Via
The Motley Fool
Topics
Initial Public Offering
Regulatory Compliance
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones
↗
November 27, 2025
One fast-rising biotech is gearing up for pivotal trials just as a major specialist fund walks away—here’s what long-term investors should take from that divergence.
Via
The Motley Fool
Topics
Initial Public Offering
Regulatory Compliance
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
November 07, 2025
The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results...
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
This Twist Bioscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
↗
November 04, 2025
Via
Benzinga
Which stocks have an unusual volume on Thursday?
↗
September 25, 2025
Let's have a look at the stocks with an unusual volume in today's session.
Via
Chartmill
Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
September 25, 2025
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday. Shares of Stitch Fix, Inc. (NASDAQ: SFIX) dipped 7.6% to $5.21 in pre-market trading following the...
Via
Benzinga
Topics
Stocks
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket
↗
September 25, 2025
Shares of PepGen Inc. (NASDAQ: PEPG) rose sharply in pre-market trading after the company announced the launch of an underwritten public offering of common stock and pre-funded warrants.
Via
Benzinga
Unusual volume stocks are being observed in Tuesday's session.
↗
September 23, 2025
On Tuesday, there are stocks with unusual volume. Let's take a look.
Via
Chartmill
Stock Market Today: Nasdaq Futures Rise, S&P 500 Slips Amid Mixed Trade—Kenvue, Micron Tech, Nvidia In Focus
↗
September 23, 2025
U.S. stock futures were fluctuating on Tuesday following Monday's record advances. Futures of major benchmark indices were mixed.
Via
Benzinga
Topics
Stocks
AutoZone, Micron Technology And 3 Stocks To Watch Heading Into Tuesday
↗
September 23, 2025
U.S. stock futures down, focus on AutoZone, Firefly Aerospace earnings, AAR Corp. results, MBX Biosciences public offering.
Via
Benzinga
Top stock movements in today's session.
↗
September 22, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 22, 2025
Via
Benzinga
Top movers analysis in the middle of the day on 2025-09-22: top gainers and losers in today's session.
↗
September 22, 2025
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Gold Gains Over 1%; Quantum Computing Shares Plunge
↗
September 22, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
September 22, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
PROS Holdings, MBX Biosciences, Metsera, Anywhere Real Estate And Other Big Stocks Moving Higher On Monday
↗
September 22, 2025
Via
Benzinga
Dow Falls Over 100 Points; Chicago Fed National Activity Index Rises In August
↗
September 22, 2025
Via
Benzinga
Topics
Economy
Stocks
MBX Biosciences Catapults 125%, Hitting A Nine-Month High, On Thyroid Drug Promise
↗
September 22, 2025
The company is working on an experimental treatment for a thyroid disease.
Via
Investor's Business Daily
Monday's pre-market session: top gainers and losers
↗
September 22, 2025
The US market session of Monday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
MBX Biosciences' Experimental Drug Shows Promise In Hypoparathyroidism Study
↗
September 22, 2025
MBX Biosciences reported Phase 2 trial success for once-weekly canvuparatide, with strong efficacy, safety profile, and plans for Phase 3 in 2026.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
September 22, 2025
Via
Benzinga
Why MBX Biosciences Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket
↗
September 22, 2025
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
